Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine
Cancer Gene Therapy, Published online: 04 September 2023; doi:10.1038/s41417-023-00658-3Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: D. C. A. Quixabeira E. Jirovec S. Pakola R. Havunen S. Basnet J. M. Santos T. V. Kudling J. H. A. Clubb L. Haybout V. Arias S. Gr önberg-Vähä-Koskela V. Cervera-Carrascon A. Pasanen M. Anttila J. Tapper A. Kanerva A. Hemminki Source Type: research
More News: Adenoviruses | Cancer | Cancer & Oncology | Gene Therapy | Genetics | Ovarian Cancer | Ovaries